Developmental Core (Core B)
发展核心(核心B)
基本信息
- 批准号:10153671
- 负责人:
- 金额:$ 63.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAcademic Medical CentersAcademic skillsAcquired Immunodeficiency SyndromeAfrican AmericanApplications GrantsAwardBloodCenter for Translational Science ActivitiesClinical ResearchCollaborationsCommunicable DiseasesCommunitiesDevelopmentDoctor of PhilosophyEnsureEvaluationExtramural ActivitiesFacultyFeedbackFosteringFundingFunding AgencyFunding MechanismsFunding OpportunitiesGoalsGrantHIVHealthHeartImmunologyInstitutesInstitutionLeadLeadershipLinkLogisticsLungManuscriptsMedical centerMedicineMentored Clinical Scientist Development ProgramMentorsMentorshipMicrobiologyNational Heart, Lung, and Blood InstituteNational Institute of Allergy and Infectious DiseasePeriodicityPhysiciansPhysiologyPilot ProjectsPositioning AttributeProductivityPublic HealthResearchResearch PersonnelResearch Project GrantsResearch TrainingResource DevelopmentResourcesRoleScientistSeriesSleepStrategic PlanningStructureTeacher Professional DevelopmentTennesseeTrainingTranslational ResearchTuberculosisUnited States National Institutes of HealthWomen&aposs HealthWorkWritingbasecareercareer developmentcommunity organizationscomorbidityexperiencehealth disparityinnovationmedical schoolsmeetingsmembermid-career facultyminority healthminority investigatoroutreachprofessorprogramsresponseskill acquisitionskillssuccess
项目摘要
Developmental Core – PROJECT SUMMARY
The Tennessee Center for AIDS Research (CFAR) is a four-way partnership between a research-intensive
institution (Vanderbilt University Medical Center), a historically black medical college (Meharry Medical College),
an academically-engaged state health department (Tennessee Department of Health), and a sophisticated
community-based organization with a 25-year exclusive focus on HIV (Nashville CARES). The Developmental
Core (DC) will support and enhance collaborative, interdisciplinary HIV/AIDS research at the four partner
institutions. Invigorated by new DC initiatives and leadership, the DC will pursue three complementary objectives:
1) To administer a robust CFAR DC Awards program that supports interdisciplinary HIV research projects and
new HIV research pilot projects; 2) To ensure mentoring of investigators new to HIV research, with a focus on
early stage, minority, women, and public health investigators, to enhance competitiveness for extramural funding,
and; 3) To foster academic skills development and scientific team-building. In 2019, the DC leadership structure
transitioned, with John Koethe, MD, MSCI, Associate Professor of Medicine at Vanderbilt, assuming the role of
DC Director, supported by Fernando Villalta, PhD and Tim Sterling, MD as Associate Directors. This change was
in response to extensive strategic planning, with input from the our CFAR External and Internal Scientific
Advisory Boards, as part of succession planning for the upcoming funding cycle of this CFAR. The DC will not
only provide DC Award funding for promising early-stage investigators but will continue to assure that there is
appropriate mentoring together with activities to foster team building. This will help early-stage investigators
appreciate the critical importance of effective collaboration as they develop into accomplished academic
research scientists. The HIV-focused DC Awards, mentoring, and skills development will be leveraged with
outstanding institutional support at Vanderbilt (through the Vanderbilt Institute for Clinical and Translational
Research; VICTR) and at Meharry (through the Meharry Translational Research Center; MeTRC, and the Center
for Health Disparities Research at MMC) to maximize the potential for important, ground-breaking research that
will lead to extramural funding support, and that ultimately has substantial impact on the burden of HIV in
Tennessee, the nation, and worldwide.
发展核心——项目摘要
田纳西州艾滋病研究中心 (CFAR) 是一个研究密集型机构之间的四向合作伙伴关系
机构(范德比尔特大学医学中心),一所历史悠久的黑人医学院(梅哈里医学院),
一个从事学术工作的州卫生部门(田纳西州卫生部门),以及一个成熟的
25 年来专门关注艾滋病毒的社区组织 (Nashville CARES)。
核心(DC)将支持和加强四个合作伙伴的跨学科艾滋病毒/艾滋病研究合作
在 DC 的新举措和领导力的推动下,DC 将追求三个互补的目标:
1) 管理强大的 CFAR DC 奖项计划,支持跨学科艾滋病毒研究项目和
新的艾滋病毒研究试点项目;2) 确保对刚接触艾滋病毒研究的研究人员进行指导,重点是
早期阶段、少数族裔、妇女和公共卫生调查员,以增强外部资金的竞争力,
3) 促进学术技能发展和科学团队建设 2019 年,DC 领导结构。
范德比尔特大学医学副教授 John Koethe(医学博士、MSCI)接任
DC 主任,由 Fernando Villalta 博士和 Tim Sterling 医学博士作为副主任支持。
根据我们的 CFAR 外部和内部科学部门的意见,响应广泛的战略规划
作为 CFAR 下一个资助周期继任计划的一部分,顾问委员会将不会这样做。
只为有前途的早期研究人员提供 DC 奖资助,但将继续确保有
适当的指导以及促进团队建设的活动这将有助于早期研究人员。
在他们发展成学术成就的过程中,认识到有效合作的至关重要性
研究科学家将利用以艾滋病毒为重点的 DC 奖项、指导和技能发展。
范德比尔特大学出色的机构支持(通过范德比尔特临床和转化研究所)
研究;VICTR)和梅哈里(通过梅哈里转化研究中心;MeTRC 和该中心)
MMC 的健康差异研究)最大限度地发挥重要的突破性研究的潜力
将带来外部资金支持,最终对艾滋病毒负担产生重大影响
田纳西州、全国乃至全世界。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Koethe其他文献
John Koethe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Koethe', 18)}}的其他基金
Cardiometabolic Consequences And Pathway Of Weight Gain Associated With Dolutegravir-Based Antiretroviral Therapy In Haiti. A Collaborative Study Between GHESKIO And CCASAnet
海地基于多替拉韦的抗逆转录病毒治疗相关的心脏代谢后果和体重增加途径。
- 批准号:
10750906 - 财政年份:2023
- 资助金额:
$ 63.05万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
10417013 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
9885568 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
Ectopic Lipid in Skeletal Muscle is Associated with Glucose Intolerance in Veterans with HIV
骨骼肌中的异位脂质与感染艾滋病毒的退伍军人的葡萄糖不耐受有关
- 批准号:
10651630 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
脂肪驻留 T 细胞在 HIV 相关葡萄糖不耐受中的作用
- 批准号:
9429306 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
The Role of Adipose-Resident T Cells in HIV-Associated Glucose Intolerance
脂肪驻留 T 细胞在 HIV 相关葡萄糖不耐受中的作用
- 批准号:
10093023 - 财政年份:2017
- 资助金额:
$ 63.05万 - 项目类别:
Innate and Adaptive Immunity in HIV-associated Impaired Glucose Tolerance and Diabetes
HIV 相关糖耐量受损和糖尿病中的先天免疫和适应性免疫
- 批准号:
9260968 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
Tennessee Center for AIDS Research (TN-CFAR)
田纳西州艾滋病研究中心 (TN-CFAR)
- 批准号:
10617275 - 财政年份:2015
- 资助金额:
$ 63.05万 - 项目类别:
相似海外基金
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
- 批准号:
10259747 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
UEM-Vanderbilt Academic Partnership for Enhancements in Research (APER)
UEM-范德堡大学研究增强学术合作伙伴关系 (APER)
- 批准号:
10400635 - 财政年份:2020
- 资助金额:
$ 63.05万 - 项目类别:
VU-Mozambique Collaborative Research Ethics Education Program
自由大学-莫桑比克合作研究伦理教育项目
- 批准号:
8845448 - 财政年份:2014
- 资助金额:
$ 63.05万 - 项目类别:
VU-Mozambique Collaborative Research Ethics Education Program
自由大学-莫桑比克合作研究伦理教育项目
- 批准号:
8989576 - 财政年份:2014
- 资助金额:
$ 63.05万 - 项目类别: